Compare Nuwellis Inc (NUWE) vs Vanguard Short Term Corporate Bond ETF (VCSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Vanguard Short Term Corporate Bond ETF — how do they compare? Nuwellis Inc trades at $2.94 (market cap $1.09M), while Vanguard Short Term Corporate Bond ETF trades at $78.58. Which is the better fit depends on your goals.
| NUWE | VCSH | |
|---|---|---|
Market Cap | $1.09M | — |
Sector | Technology | Fixed Income |
52-Week High | $527.46 | $80.20 |
52-Week Low | $2.80 | $78.45 |
Enterprise Value | -$722.58K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Vanguard Short Term Corporate Bond ETF
VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.
Read more on VCSH →
